Psyence Biomedical Ltd Sustainability Reports
A biopharmaceutical company specializing in the development of botanical, natural psilocybin-based psychedelic medicines for mental health disorders, particularly in palliative care.
Sector: Manufacturing
Country: Canada
Exchange: Nasdaq
1 reports from 2025 to 2025
Company Profile
A biopharmaceutical company specializing in the development of botanical, natural psilocybin-based psychedelic medicines for mental health disorders, particularly in palliative care.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
